Skip to main navigation Skip to search Skip to main content

A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

  • Rachel Galot
  • , Christophe Le Tourneau
  • , Esma Saada-Bouzid
  • , Amaury Daste
  • , Caroline Even
  • , Philip Debruyne
  • , Stéphanie Henry
  • , Sylvie Zanetta
  • , Anemie Rutten
  • , Lisa Licitra
  • , Jean-Luc Canon
  • , Marie-Christine Kaminsky
  • , Pol Specenier
  • , Sylvie Rottey
  • , Joël Guigay
  • , Anthony Kong
  • , Inge Tinhofer
  • , Edith Borcoman
  • , Lieve Dirix
  • , Tiana Raveloarivahy
  • Catherine Fortpied, Maureen Vanlancker, Marie Morfouace, Anne-Sophie Govaerts, Jean-Pascal Machiels

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)17-26
JournalEuropean Journal of Cancer
Volume158
Early online date9 Oct 2021
DOIs
Publication statusPublished - 1 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this